Colgate-Palmolive stock had its Relative Strength (RS) Rating upgraded from 78 to 81 Wednesday.
IBD's proprietary RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the last 52 weeks matches up against the rest of the market.
Decades of market research reveals that the best stocks often have an RS Rating of over 80 as they launch their biggest climbs.
Risk Management In The Stock Market: How Much Money To Invest Now
Is Colgate-Palmolive Stock A Buy?
Colgate-Palmolive stock has climbed more than 5% past a 95.59 entry in a first-stage flat base, meaning it's now extended and out of a proper buy zone. Look for the stock to offer a new chance to pick up shares like a three-weeks tight or pullback to the 50-day or 10-week moving average.
The consumer staples firm posted 18% EPS growth in its most recent report, while sales growth came in at 5%. Keep an eye out for the company's next round of numbers on or around Oct. 25.
Colgate-Palmolive stock earns the No. 5 rank among its peers in the Cosmetics/Personal Care industry group. FitLife Brands is the top-ranked stock within the group.
